|
市場調査レポート
商品コード
1245711
内視鏡流体管理の世界市場規模、シェア、産業動向分析レポート用途別、製品別、エンドユーザー別、地域別展望と予測、2022年~2028年Global Endoscopy Fluid Management Market Size, Share & Industry Trends Analysis Report By Application, By Product, By End User, By Regional Outlook and Forecast, 2022 - 2028 |
||||||
内視鏡流体管理の世界市場規模、シェア、産業動向分析レポート用途別、製品別、エンドユーザー別、地域別展望と予測、2022年~2028年 |
出版日: 2023年02月28日
発行: KBV Research
ページ情報: 英文 198 Pages
納期: 即納可能
|
内視鏡流体管理の世界市場規模は、予測期間中にCAGR 7.2%で成長し、2028年には9億7,000万米ドルに達すると予測されています。
体液吸収の増加は、子宮内圧が高い、子宮筋層が深く入り込んでいる、子宮内圧が高い、子宮が大きいなどと関連しています。泌尿器科の内視鏡検査は、尿路に関連する問題を診断するために行われます。内視鏡検査には、尿管鏡検査と膀胱鏡検査の2種類があります。膀胱鏡検査は膀胱と尿道の中を観察するもので、尿管鏡検査は尿管と腎臓の中を観察するものです。
技術の進歩により、侵襲的な泌尿器科手術が可能になりました。合併症のリスクが低く、効率的な手術が特徴です。例えば、尿道から腎臓結石を摘出する手術などです。内視鏡手術の際、術野に圧力をかけた液体を送り込むための医療用ポンプ。関節鏡は、プロスポーツで重要な怪我である前十字靭帯損傷の治療に役立っています。流体管理システムの圧力は、可能な限り低く設定されるか、または視界を確保するための要件に従って設定されます。
COVID-19の影響度分析
COVID-19は、世界中のヘルスケアシステムにストレスを与えています。このパンデミックは、医療機器メーカーやヘルスケアプロバイダーが内視鏡流体管理システムに取り組む方法を変えました。COVID-19のパンデミックは、消化器科などの多くのサブスペシャリストや処置関連分野に影響を与えました。相当数の病院や診療所が、COVID-19と診断された患者への対応能力を高めるために再編成されました。また、これらの内視鏡処置のかなりの割合がロックダウンのために影響を受け、内視鏡流体管理市場の成長に悪影響を及ぼすと予想されます。
市場の成長要因
低侵襲手術の増加により
低侵襲手術は、従来の開腹手術に比べて外傷が非常に少ないです。従来の腹腔鏡器具で行われる手術は、外傷が多く、複雑なものでした。しかし、低侵襲手術では、小さな切開口から腹腔鏡カメラを挿入し、小型の専用器具を使用して手術を行います。また、痛みも少なく、患者さんの回復も早くなります。回復が早く、切開創が小さく、精度が高く、入院期間が短く、傷跡や痛みが少ないことから、これらの手術の人気は高まっています。さらに、これらの医療用ディスプレイは、細胞や組織のごくわずかな違いさえも提供し、優れた視認性を確保し、迅速かつ正確な手術を可能にします。これが地域市場の成長を支えています。
消化器系がんの患者数の増加
GIがんの負担は、経済発展途上国に移行しており、通常、増加する罹患率に対処するためのヘルスケアリソースが不足していることがわかりました。5つの主要なタイプのGIがんの各タイプについて、新規症例数と死亡数が増加すると予想されています。このがんは、感染症、たばこ喫煙、食事、運動不足、飲酒、肥満とも関連しています。特に新興諸国では、GIがんの症例が増加しているため、内視鏡による流体管理の利用が急増し、予測期間中の市場拡大が後押しされるでしょう。
市場抑制要因
内視鏡の代替手段
内視鏡検査を受ける患者さんは、多くの患者さんにとって不快感や痛みを伴う可能性があるため、一般的に麻酔をかけたり、軽い鎮静剤を使用したりしますが、CTスキャンを受けるほとんどの人は鎮静剤を必要としません。また、CTスキャンはほぼすべての年齢の人に行うことができますが、内視鏡検査はほとんどが成人に対して行われます。CTスキャンは痛みがなく、鎮静剤も不要なため、内視鏡検査の代替となる可能性があり、内視鏡検査による体液管理の市場成長が妨げられると予想されます。
製品の展望
製品に基づき、内視鏡流体管理市場はシステムとアクセサリーに区分されます。2021年の内視鏡流体管理市場では、アクセサリ分野がかなりの収益シェアを獲得しました。これは、治療や組織サンプルの採取にこれらのアクセサリーが使用されるためです。内視鏡にはチャンネルがあり、それを通して医師は患者の体内にツールを挿入することができます。これらのツールには、組織サンプルを採取するフレキシブル鉗子、疑わしい成長を取り除くために使用する生検鉗子、細胞サンプルを採取する細胞診ブラシ、体内の縫合糸を取り除くために使用する縫合糸除去鉗子があります。
アプリケーションの展望
用途別では、内視鏡流体管理市場は腹腔鏡、子宮鏡、その他に分けられます。2021年の内視鏡流体管理市場では、腹腔鏡検査部門が最も高い収益シェアを占めています。これは、腹腔鏡手術の件数が増加しているためです。現在、多くの個人が診断や治療のために低侵襲な処置を選ぶようになっています。また、世界的に老年人口が増加していることも、内視鏡流体管理システムの需要をさらに高めています。これらの要因が、予測される期間中にこのセグメントの成長を促進すると予想されます。
エンドユーザーの展望
エンドユーザー別では、内視鏡流体管理市場は病院、クリニック、その他に分類されます。病院セグメントは、2021年に最大の収益シェアを獲得して内視鏡流体管理市場をリードしました。これは、このようなヘルスケア環境において、多数の外科的処置のための患者の入院数が増加していることに起因しています。内視鏡手術が増加し、高度な病院が開発されているのです。また、多くの政府機関が外科手術の能力強化に力を入れています。これらの要因が、この分野の拡大を加速させると予想されます。
地域別展望
地域別では、内視鏡流体管理市場は、北米、欧州、アジア太平洋、LAMEAで分析されています。北米地域は、2021年の内視鏡流体管理市場で最も高い収益シェアを獲得しました。これは、内視鏡処置中に内部空洞の出血を減少させるために正確な圧力を維持するために、これらのシステムによって提供される支援に起因します。ハイテク機器を利用することで、治療のコンプライアンスが向上します。また、この地域は、高度に熟練した医療従事者、ハイテク技術、強固なヘルスケアインフラを有しています。また、この分野をさらに強化するための政府による多くの政策が、この地域での医療機器の利用を増加させ、市場の成長を促進すると期待されています。
市場参入企業がとる主な戦略は、製品の発売です。カーディナルマトリックスに掲載された分析によると、メドトロニックPLCが内視鏡流体管理市場の先駆者となっています。Olympus Corporation、Stryker Corporation、Hologic, Inc.などの企業は、内視鏡流体管理市場における主要な革新者の一人です。
List of Figures
The Global Endoscopy Fluid Management Market size is expected to reach $970 Million by 2028, rising at a market growth of 7.2% CAGR during the forecast period.
Endoscopy fluid management is a medical device that assists in managing fluids during endoscopic procedures. These systems generally contain a suction device, a fluid collection unit, and a disposable fluid system. the fluid collection unit collects and stores fluid during endoscopic procedures. The suction device are used to remove fluids from the patient's body and carry them to the fluid collection unit. The disposable fluid system treats and disposes of the collected fluids in a manner that is environment friendly.
An endoscopy fluid management system is required in all endoscopy procedures, including laparoscopy, arthroscopy, hysteroscopy, and urology. A laparoscopy is a surgical, diagnostic procedure conducted utilizing laparoscopy and aids in evaluating the organs inside the abdomen. It's a minimally invasive procedure that needs only small incisions. In hysteroscopy, systemic absorption of the uterine distension fluid occurs majorly through disrupted endometrial and myometrial venous sinuses due to the pressure gradient between the uterine cavity and open vessels or sinuses.
The increased fluid absorption is linked with high intrauterine pressure, deep myometrial penetration, higher intrauterine pressure, and large uteri. Urology endoscopies are done to diagnose the issues related to the urinary tract. Endoscopies come in two forms one is ureteroscopy, and the other is cystoscopy. A cystoscopy utilizes a cystoscope to look inside the bladder and urethra, whereas a ureteroscopy utilizes a ureteroscopy to look inside the ureters and kidneys.
With technological advancements, it is possible to conduct invasive urological surgeries. Lower risk of complications and high efficiency characterizes them. For instance, the removal of kidney stones through the urethra. A medical pump is designed to deliver fluid under pressure to an operating area during endoscopy. Arthroscopy aids in treating anterior cruciate ligament (ACL) injury, a significant injury in professional sports. Fluid management system pressure is set as low as possible or per the requirement to obtain a view.
COVID-19 Impact Analysis
COVID-19 has put the healthcare system under stress around the world. The pandemic has altered how medical device manufacturers and healthcare providers approach endoscopy fluid management systems. The COVID-19 pandemic affected numerous sub-specialists and procedure-related fields such as gastroenterology. A considerable number of hospitals and clinics were restructured to raise their capacity for the patient diagnosed with COVID-19. In addition, a significant proportion of these endoscopic procedures were affected due to the lockdowns, which is expected to have a negative impact on the growth of the endoscopy fluid management market.
Market Growth Factors
The increasing number of minimally invasive surgeries
Surgeries which are minimally invasive are much less traumatic than conventional open surgeries. Surgeries performed with traditional laparoscopic instruments were traumatic and complex. But in minimally invasive surgeries, laparoscopic cameras are inserted through smaller incisions, and small specialized instruments are utilized to perform the operation. The recovery is also less painful, and patients recover faster. The popularity of these surgeries are increasing due to the quicker recovery, smaller incisions, high accuracy, shorter hospital stays, and less scarring & pain. In addition, these medical displays provide even the most negligible difference in cells and tissues, ensure superior visibility, and enable rapid and precise surgery. This supports the growth of the regional market.
The rising cases of gastrointestinal cancer
It was seen that the burden of GI cancers has continued to shift towards economically developing nations which usually have fewer healthcare resources to manage the rising incidence. The number of new cases and death for each type of the five major types of GI cancers are expected to increase. This cancer is also associated with infection, tobacco smoking, diet, physical inactivity, alcohol consumption, and obesity. The increasing cases of GI cancers, especially in developing countries, will surge the utilization of endoscopy fluid management, boosting the market expansion in the projected period.
Market Restraining Factors
Alternatives to endoscopy
Patients undergoing endoscopy are generally provided with anesthetic or are mildly sedated as the procedure might be uncomfortable or painful to many patients, while almost all individuals undergoing a CT scan don't require any sedation. In addition, CT scans can be done on people of nearly every age, while most endoscopy procedures are done on adults. The painlessness and the requirement of no type of sedatives in the CT scans might make them a better alternative to endoscopy; hence the market growth for endoscopy fluid management is expected to hinder.
Product Outlook
Based on product, the endoscopy fluid management market is segmented into system and accessories. The accessories segment acquired a substantial revenue share in the endoscopy fluid management market in 2021. This is due to the usage of these accessories to provide treatment or collect tissue samples. An endoscope has a channel through which the doctor can insert tools into the patient's body. These tools include flexible forceps, which take the tissue sample; biopsy forceps which are used to remove any suspicious growth; cytology brushes which take the cell sample and suture removal forceps, which are used to remove stitches inside the body.
Application Outlook
On the basis of application, the endoscopy fluid management market is divided into laparoscopy, hysteroscopy and others. The laparoscopy segment held the highest revenue share in the endoscopy fluid management market in 2021. This is because of the increasing number of laparoscopy procedures. Many individuals are now opting for minimally invasive procedures for diagnosis and treatment. In addition, the rising geriatric population globally is further increasing the demand for endoscopy fluid management systems. These factors are anticipated to propel the segment's growth during the projected period.
End User Outlook
By end user, the endoscopy fluid management market is classified into hospital, clinics and others. The hospital segment led the endoscopy fluid management market by generating the maximum revenue share in 2021. This is due to the rising number of patient admissions for numerous surgical procedures in such healthcare settings. There is an increase in endoscopy procedures and the development of advanced hospitals. Also, many governmental bodies are now concentrating on enhancing the capacity for surgical procedures. These factors are anticipated to surge the expansion of the segment.
Regional Outlook
Region-wise, the endoscopy fluid management market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region generated the highest revenue share in the endoscopy fluid management market in 2021. This is due to the assistance provided by these systems in maintaining precise pressure to decrease the bleeding in internal cavities during endoscopic procedures. Utilizing high-tech devices enhances treatment compliance. The region also has highly skilled medical professionals, high-tech technology, and a robust healthcare infrastructure. Also, many policies by the government to further enhance the sector is expected to increase their utilization and propel the market growth in the region.
The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; Medtronic PLC is the forerunners in the Endoscopy Fluid Management Market. Companies such as Olympus Corporation, Stryker Corporation, Hologic, Inc. are some of the key innovators in Endoscopy Fluid Management Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Olympus Corporation, Steris PLC, B. Braun Melsungen AG, Stryker Corporation, Hologic, Inc., ConMed Corporation, Karl Storz SE & Co. KG, Arthrex, Inc., and COMEG Medical Technologies (Acteon Group).
Strategies Deployed in Endoscopy Fluid Management Market
2022-Dec: Olympus came into an agreement to acquire Odin Vision, a UK-based cloud-AI endoscopy start-up. Through this acquisition, Olympus aims to strengthen its capabilities to deliver data-driven insights and advanced AI-powered solutions which can transform patient care and enhance clinical and procedural workflows.
2022-Feb: Stryker took over Vocera Communications, Inc., a company involved in digital care coordination and communication. Through this acquisition, Stryker would advance innovations and boost its digital aspirations. Additionally, both companies would work together to allow safer patient care and support their customers to enhance outcomes.
2021-Nov: Medtronic received FDA approval for PillCam Small Bowel 3 system. The PillCam SB3 integrates Medtronic's PillCam technology with Amazon logistics, integration developed to ensure both timely and precise results for patients from the convenience of their homes.
2021-Oct: Arthrex expanded its global footprint by setting up a new facility in Anderson County, United States. The new plant is expected to create 500 new jobs. The new plant reflects Arthrex's commitment to manufacturing supreme quality products in the United States and further aids Arthrex in the growth and development of new products.
2021-Jun: STERIS plc took over Cantel Medical, a provider of infection prevention products and services to dental, dialysis, endoscopy, and life sciences Customers. This acquisition would complement and broaden Steris's product and service portfolio, customers, and global.
2021-Apr: Medtronic released GI Genius, a medical device that utilizes artificial intelligence to assist clinicians to identify in real-time any potential irregularities in the colon during colonoscopies. Colonoscopies allow gastroenterologists to detect polyps and lesions that might develop into cancer as a means of screening and surveillance.
2020-Oct: Olympus Corporation launched ENDO-AID, a product that allows real-time display of automatically detected suspicious lesions. ENDO-AID works together with the newly released EVIS X1, Olympus' most advanced endoscopy system to date.
2020-Mar: KARL STORZ unveiled TELE PACK + system, a mobile, compact endoscopy system. The product is a portable video system created to integrate all the important components, consisting of the camera control unit, light source, and display needed for endoscopic diagnosis and treatment, including data management and image capture.
2018-Aug: Hologic launched the Fluent system, a fluid management system for hysteroscopic procedures across the United States. The product is developed in response to the issues faced by doctors and nurses performing hysteroscopies. The Fluent System consists of advanced technology with a modernized design for highly efficient fluid monitoring during procedures.
2018-May: Olympus unveiled DualKnife JTM, an endoscopic submucosal dissection (ESD) electrosurgical knife. The product combines submucosal injection to assist safe, efficient, and highly reliable ESD performance.
Market Segments covered in the Report:
By Application
By Product
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research